Standout Papers

Low-Dose Colchicine for Secondary Prevention of Coronary Artery Disease 2023 2026 202488
  1. Low-Dose Colchicine for Secondary Prevention of Coronary Artery Disease (2023)
    Kyle A. Nelson, Valentı́n Fuster et al. Journal of the American College of Cardiology

Immediate Impact

41 standout
Sub-graph 1 of 19

Citing Papers

The airway epithelium: an orchestrator of inflammation, a key structural barrier and a therapeutic target in severe asthma
2024 Standout
Effect of Colchicine on Coronary Plaque Stability in Acute Coronary Syndrome as Assessed by Optical Coherence Tomography: The COLOCT Randomized Clinical Trial
2024 Standout

Works of Kyle A. Nelson being referenced

Low-Dose Colchicine for Secondary Prevention of Coronary Artery Disease
2023 Standout
Omalizumab Is Associated with Reduced Acute Severity of Rhinovirus-triggered Asthma Exacerbation
2016

Author Peers

Author Last Decade Papers Cites
Kyle A. Nelson 134 104 86 105 30 437
Diego Martínez‐Urbistondo 69 48 23 118 39 473
Joongbum Cho 124 31 79 163 45 466
Meltem Refıker Ege 109 30 49 109 28 434
Linda Kirschenbaum 100 32 65 150 15 425
Phoebe H. Yager 76 78 83 54 38 485
Shyoko Honiden 113 27 54 101 27 416
Abhishek Chaturvedi 68 24 31 64 44 454
Elder Granger 61 36 35 84 28 408
Sumedh S. Hoskote 119 59 50 93 39 453
C Robertson 93 43 226 39 30 415

All Works

Loading papers...

Rankless by CCL
2026